New ideas about atrial fibrillation 50 years on

Nature

Volumn 415, Issue 6868, 2002, Pages 219-226

  Nattel, Stanley ^a  

^a MONTREAL HEART INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MEDICAL PROBLEMS;

ATRIAL FIBRILLATION;

BIOLOGICAL ORGANS;

DISEASE;

HEART ATRIUM CONTRACTION; HEART ATRIUM FIBRILLATION; HEART RHYTHM; MORBIDITY; MORTALITY; PRIORITY JOURNAL; REVIEW; SINUS NODE;

ANIMALS; ATRIAL FIBRILLATION; ELECTROPHYSIOLOGY; FORECASTING; HUMANS; MODELS, BIOLOGICAL; PULMONARY VEINS; SINOATRIAL NODE;

EID: 0037050001     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/415219a     Document Type: Review

References (80)

1. Impact of a trial fibrillation on the risk of death. The Framingham heart study
2. The epidemiology of heart failure: The Framingham study
3. Tachycardiomyopathy: Mechanisms and clinical implications
4. Atrial fibrillation and stroke: Concepts and controversies
5. Experimental evidence for proarrhythmic mechanisms of antiarrhythmic drugs
6. Newer developments in the management of atrial fibrillation
7. Auricular fibrillation
8. New surgical and catheter-based modifications of the Maze procedure
9. A computer model of atrial fibrillation
10. Circus movement in rabbit atrial muscle as a mechanism of tachycardia. III. The "leading circle" concept: A new model of circus movement in cardiac tissue without the involvement of an anatomical obstacle
11. Length of excitation wave and susceptibility to reentrant atrial arrhythmias in normal conscious dogs
12. Stable microreentrant sources as a mechanism of atrial fibrillation in the isolated sheep heart
13. Left-to-right gradient of atrial frequencies during acute atrial fibrillation in the isolated sheep heart
14. Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation
15. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins
16. Ionic mechanism of repolarization differences between canine right and left atrium
17. Method for simultaneous epicardial and endocardial mapping of the in vivo canine heart: Application to atrial conduction properties and arrhythmia mechanisms
18. Basic mechanisms of atrial fibrillation-very new insights into very old ideas
19. + current in human atrial myocytes
20. + current similar to Kv1.5 cloned channel currents
21. Evidence for two components of delayed rectifier potassium current in human ventricular myocytes
22. Antisense oligonucleotides directed against Kv1.5 mRNA specifically inhibit ultrarapid delayed rectifier potassium current in cultured adult human atrial myocytes
23. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats
24. Electrical remodeling due to atrial fibrillation in chronically instrumented conscious goats: Roles of neurohumoral changes, ischemia, atrial stretch, and high rate of electrical activation
25. Intracellular calcium changes and tachycardia-induced contractile dysfunction in canine atrial myocytes
26. Ionic mechanisms underlying human atrial action potential properties: Insights from a mathematical model
27. Molecular mechanisms underlying ionic remodeling in a dog model of atrial fibrillation
28. Gene expression of proteins influencing the calcium homeostasis in patients with persistent and paroxysmal atrial fibrillation
29. 2+-ATPase mRNA in human atrial fibrillation without significant change in the mRNA of ryanodine receptor, clasequestrin and phospholamban. An insight into the mechanism of atrial electrical remodeling
30. Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation
31. 2+ currents and human atrial fibrillation
32. Ionic mechanisms of electrical remodeling in human atrial fibrillation
33. Functional mechanisms underlying tachycardia-induced sustained atrial fibrillation in a chronic dog model
34. The cellular mechanisms of atrial contractile dysfunction caused by sustained atrial tachycardia
35. 2+ regulatory proteins in the atrial tissue of patients with chronic atrial fibrillation
36. Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat
37. Exclusion of atrial thrombus by transesophageal echocardiography does not preclude embolism after cardioversion of atrial fibrillation. A multicenter study
38. Tachycardia-induced changes in sodium current in a chronic dog model of atrial fibrillation
39. + current densities and Kv1.5 expression are reduced in chronic human atrial fibrillation
40. Radiofrequency catheter ablation of the atrial eliminates pacing-induced sustained atrial fibrillation and reduces connexin 43 in dogs
41. Gap junctional remodeling in relation to stabilization of atrial fibrillation in the goat
42. The gap-junctional protein connexin 40 is elevated in patients susceptible to postoperative atrial fibrillation
43. The effects of experimental heart failure on atrial cellular and ionic electrophysiology
44. Promotion of atrial fibrillation by heart failure in dogs: Atrial remodeling of a different sort
45. Atrial tachycardia in dogs with ventricular pacing-induced congestive heart failure originates from multiple foci in the crista terminalis and pulmonary veins: Experimental evidence supporting the "atrial ring of fire" hypothesis
46. Incresed expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation
47. Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans
48. Expression and activity of ectopeptidases in fibrillating human atria
49. Myocardial cell death in fibrillating and dilated human right atria
50. Effects of angiotensin converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure
51. Role of apoptosis and tissue fibrosis in arrhythmogenic atrial structural remodeling in a canine model of congestive heart failure
52. Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction
53. Familiäres idiopathisches vorhofflimmern mit bradyarrhythmie
54. Identification of a genetic locus for familial atrial fibrillation
55. Conduction disturbances and increased atrial vulnerability in connexin 40-deficient mice analyzed by transesophageal stimulation
56. Cardiac-specific overexpression of RhoA results in sinus and atrioventricular nodal dysfunction and contractile failure
57. Atrial but not ventricular fibrosis in mice expressing a mutant transforming growth factor-β 1 transgene in the heart
58. Inducibility of atrial arrhythmias in transgenic mice with selective atrial fibrosis die to overexpression of TGFβ-1
59. Tachycardia-induced change of atrial refractory period in humans: Rate dependency and effects of antiarrhythmic drugs
60. Effect of verapamil and procainamide on atrial fibrillation-induced electrical remodeling in humans
61. Verapamil reduces tachycardia-induced electrical remodeling of the atria
62. Effect of verapamil on long-term tachycardia-induced atrial electrical remodeling
63. Differential efficacy of L- and T-type calcium channel blockers in preventing tachycardia-induced atrial remodeling in dogs
64. 2+ channel blocker mibefradil prevents the development of a substrate for atrial fibrillation by tachycardia-induced atrial remodeling in dogs
65. 2+ current at physiologic temperatures relevant to the action potential in human atrial myocytes
66. Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation
67. The role of atrial electrical remodeling in the progression of focal atrial ectopy to persistent atrial fibrillation
68. Relation between ligament of Marshall and adrenergic atrial tachyarrhythmia
69. Initiation of atrial fibrillation by ectopic beats originating from the superior vena cava: Electrophysiological characteristics and results of radio frequency ablation
70. Pulmonary veins and ligament of Marshall as sources of rapid activations in a canine model of sustained atrial fibrillation
71. Role of rapid focal activation in the maintenance of atrial fibrillation originating from the pulmonary veins
72. Efficacy of pulmonary vein isolation for the elimination of chronic atrial fibrillation in cardiac valvular surgery
73. Electrical activity of the pulmonary vein and its interaction with the right atrium in the guinea-pig
74. Arrhythmogenic activity of cardiac muscle in pulmonary veins of the dog: Implication for the genesis of atrial flbrillation
75. Tarantula peptide inhibits atrial fibrillation
76. Distribution and prevalence of hyperpolarization-activated cation channel (HCN) mRNA expression in cardiac tissues
77. Spiral waves in two-dimensional models of ventricular muscle: Formation of a stationary core
78. Trantmembrane potential properties at the core of functional reentrant wave fronts in isolated canine right atria
79. How do class I antiarrhythmic drugs terminate atrial fibrillation? A quantitative analysis based on a realistic ionic model
80. Widening of the excitable gap during pharmacological cardioversion of atrial fibrillation in the goat: Effects of cibenzoline, hydroquinidine, flecainide, and D-sotalol